Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Empowered Funds LLC

Empowered Funds LLC trimmed its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 16.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 22,399 shares of the pharmacy operator’s stock after selling 4,258 shares during the quarter. Empowered Funds LLC’s holdings in Walgreens Boots Alliance were worth $201,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Iron Horse Wealth Management LLC raised its holdings in Walgreens Boots Alliance by 162.5% in the 2nd quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 1,300 shares during the period. Blue Trust Inc. increased its position in shares of Walgreens Boots Alliance by 87.0% during the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock valued at $28,000 after acquiring an additional 1,081 shares during the last quarter. Continuum Advisory LLC raised its stake in shares of Walgreens Boots Alliance by 71.2% in the 2nd quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock valued at $30,000 after acquiring an additional 1,020 shares during the period. Sentry Investment Management LLC acquired a new position in shares of Walgreens Boots Alliance in the 3rd quarter worth approximately $30,000. Finally, Eastern Bank purchased a new position in shares of Walgreens Boots Alliance during the 3rd quarter worth approximately $33,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Trading Down 3.6 %

Walgreens Boots Alliance stock opened at $8.73 on Wednesday. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $27.05. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68. The firm has a market capitalization of $7.55 billion, a PE ratio of -0.87, a PEG ratio of 1.14 and a beta of 0.69. The business’s 50-day simple moving average is $9.13 and its 200-day simple moving average is $11.39.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.03. The firm had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The company’s quarterly revenue was up 5.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.67 earnings per share. Equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be issued a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 11.45%. The ex-dividend date is Monday, November 18th. Walgreens Boots Alliance’s payout ratio is -9.99%.

Analysts Set New Price Targets

A number of research analysts recently weighed in on WBA shares. JPMorgan Chase & Co. dropped their price objective on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a report on Friday, August 30th. Jefferies Financial Group dropped their price target on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research note on Wednesday, October 23rd. Bank of America reduced their price objective on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a research note on Wednesday, September 4th. Truist Financial decreased their target price on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a report on Monday, October 7th. Finally, TD Cowen cut their price target on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a report on Tuesday, October 22nd. Four research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, Walgreens Boots Alliance presently has an average rating of “Hold” and an average price target of $12.88.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.